The Sterile Injectable Contract Manufacturing Market was valued at US$ 18,395.07 Million in 2025 and is projected to reach US$ 49,738.76 Million by 2034, registering a CAGR of 11.69% during 2026–2034. The market is expanding as pharmaceutical and biotechnology companies increasingly outsource the development, manufacturing, filling, and packaging of...